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Abstract
Background: The first mammalian protein histidine phosphatase (PHP) was discovered in the late 90s of the last
century. One of the known substrates of PHP is ATP-citrate lyase (ACL), which is responsible - amongst other
functions - for providing acetyl-CoA for acetylcholine synthesis in neuronal tissues. It has been shown in previous
studies that PHP downregulates the activity of ACL by dephosphorylation. According to this our present work
focused on the influence of PHP activity on the acetylcholine level in cholinergic neurons.
Results: The amount of PHP in SN56 cholinergic neuroblastoma cells was increased after overexpression of PHP by
using pIRES2-AcGFP1-PHP as a vector. We demonstrated that PHP overexpression reduced the acetylcholine level
and induced cell death. The acetylcholine content of SN56 cells was measured by fast liquid chromatography-
tandem mass spectrometry method. Overexpression of the inactive H53A-PHP mutant also induced cell damage,
but in a significantly reduced manner. However, this overexpression of the inactive PHP mutant did not change
the acetylcholine content of SN56 cells significantly. In contrast, PHP downregulation, performed by RNAi-
technique, did not induce cell death, but significantly increased the acetylcholine content in SN56 cells.
Conclusions: We could show for the first time that PHP downregulation increased the acetylcholine level in SN56
cells. This might be a potential therapeutic strategy for diseases involving cholinergic deficits like Alzheimer’s
disease.
Background
Reversible protein phosphorylation has become one of
the most important mechanisms for regulating biological
processes, maybe because of its simplicity and flexibility
[1]. So far much is known about kinases and phospha-
tases that act on serine, threonine and tyrosine residues,
but the knowledge about histidine phosphorylation is
still fragmentary.
In the late 90s of the last century, the first mammalian
histidine phosphatase was discovered by Hermesmeier
and Klumpp [2] and described in detail by Klumpp et al.
[3] and Ek et al. [4]. PHP is a small enzyme of 13.7 kDa
that is ubiquitously expressed in mammalian tissues [3].
Structural investigations postulated histidine 53 to be
essential for catalytic function of PHP [5,6].
Several proteins, as for instance P-selectin [7], histone
H4 [8] and annexin I [9] are phosphorylated at a histidine
residue and are essential for cellular signaling without
knowing the kinase or phosphatase responsible for that.
Meanwhile, three substrates have been identified for PHP
i.e. ATP-citrate lyase (ACL) [10], the ß-subunit of the
heterotrimeric G protein (Gß) [11] and the calcium-
dependent potassium channel KCa3.1 [12].
Previous studies have shown that ACL regulates crucial
parts of intermediate metabolism in neuronal cells and
that PHP expression seems to impact ACL activity [13,14].
ACL is responsible for providing acetyl-coenzyme-A
(acetyl-coA) for synthesis of fatty acids and of acetylcho-
line (ACh), i.e. the neurotransmitter which is used by
cholinergic neurons and synthesized from choline and
acetyl-coA. Therefore our present work focussed on the
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putative influence of PHP activity on ACh content of cho-
linergic neurons. It is already known that a decreased level
of ACh is found in the brains of patients with Alzheimer’s
disease (AD) [15,16], but it is still unknown whether PHP
plays a role in regulating the ACh level in brain tissue. In a
previous study, we have developed a method for measur-
ing the ACh content in cultured cholinergic neurons [17].
In the present work, we wanted to shed some light on the
significance of PHP for the synthesis of ACh in cholinergic
neurons. We investigated the viability of SN56 cells and
measured the ACh content of these cholinergic neurons
after up- and downregulation of PHP.
Methods
Materials
Dulbecco’s modified eagle medium (DMEM), Opti-
MEM and gentamycine were obtained from Gibco
(Eggenstein, Germany). Hoechst 33258, paraformalde-
hyde and a-tubulin antibody were from Sigma-Aldrich
(Taufkirchen, Germany). Fetal bovine serum (FBS) and
Trypsin-ethylenediaminetetraacetic acid (EDTA) for
detaching SN56-cells were from PAA (Marburg, Ger-
many). Horse radish peroxidase (HRP) conjugated anti-
bodies were obtained from GE Healthcare (Freiburg,
Germany).
Monoclonal PHP antibody
Monoclonal antibody of PHP was used as previously
generated and characterized [18].
Cell culture and cell extracts
SN56.B5.G4 cells, a cholinergic murine neuroblastoma cell
line, were provided by C. Culmsee (Marburg, Germany).
The cells were cultured at 37°C in a humidified atmo-
sphere containing 5% CO2. For cultivation of SN56 cells
DMEM supplemented with 10% FBS and gentamycine
(50 μg/ml) was used. Experimental procedures with SN56
cells were performed with passages 25 - 40. At confluency,
cells were split 1:3-1:5 by incubation with trypsin/EDTA-
solution. After washing cells were cultivated in 75 cm2
flasks with 106 cells/flask.
Cell extracts for Western blot analysis were prepared
by washing cells with ice-cold phosphate buffered saline
(PBS; 13.7 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4) and were resuspended in homogeni-
zation buffer containing 50 mM Tris/HCl (pH 7.5),
1 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride
(PMSF) and 1 mM benzamidine (BZ). For disruption
cells were sonicated 3 times with 5 pulses (1/2 cycles
and 60% amplitude; sonificator: Ultrason technology,
Hielscher; Germany).
The total protein concentration was determined by
using the Lowry assay [19] based on the protocol modi-
fied by Hartree [20].
Immunoblotting
A total amount of 50 μg protein and 100 ng recombinant
(rec.) PHP were applied on 15% SDS-PAGE gels. Proteins
were transferred onto nitrocellulose membrane by semidry
blotting for 1 h at 10 V and then the membrane was
blocked with 5% non-fat milk powder in TBST. Monoclo-
nal primary PHP antibody (1:200, 0.1% bovine serum albu-
min), a-tubulin (1:10,000, 5% non-fat milk powder) as a
loading control and the appropriate secondary antibodies
conjugated to HRP(1:2,500, Sigma) were used to accom-
plish immunodetection of PHP and a-tubulin. Membranes
were incubated with the primary antibodies over night at
4°C and with the secondary antibodies for 1 h at room
temperature (RT). Immunoreactive bands were visualized
by using enhanced chemiluminescence (Thermo Sientific,
IL, USA) and automatic film processor Cawomat 200 IR
(AGFA, Germany).
Transfection of SN56 cells
SN56 cells were washed with OptiMEM supplemented
with 10% FBS and adjusted to 4,000,000 cells in 375 μl of
the same medium. After adding 26 μg DNA or 25 μl of
the siRNA solution (20 μM) in a 4 mm cuvette, electro-
poration was performed by using Genpulser Xcell (Bio-
Rad; Munich, Germany). The cells from each transfection
were seeded in a 6-well-plate for Western Blot analysis
and ACh measurement. For Hoechst 33258 staining the
transfected cells were seeded in 24-well-plates. Culture
was achieved under standard conditions in DMEM con-
taining 10% FBS, but no gentamycine.
Overexpression of PHP
Mammalian PHP overexpression vector was constructed
by inserting polymerase chain reaction (PCR) generated
cDNA, using php-pET-16b [21] as a template, in pIRES2-
AcGFP1 (Takara Bio Europe/Clontech; Saint-Germain-en-
Laye, France). The primer with the sequence 5’-atc gga att
cca tgg cgg tgg cgg a-3’ was used as a forward primer and
with the sequence 5’-cgg atc cgt cag tag ccg tcg tta gc-3’ as
a reverse primer for amplifying the PHP sequence with
PCR. Both, PHP and green fluorescent protein (GFP) were
expressed from a single bicistronic mRNA.
Site-directed mutagenesis of histidine 53 of the human
PHP sequence cloned in pIRES2-AcGF1-PHP was inserted
by PCR using oligonucleotides (H53Asense: 5’-gca gaa gtg
ggc tga gta cgc cgc gga cat cta cg-3’, H53Aanti: 5’-cgt aga
tgt ccg cgg cgt act cag ccc act tct gc-3’) of the mutated
residue. The overexpression vectors were transferred into
SN56 cells by electroporation as described under transfec-
tion of SN56 cells.
Downregulation of PHP by siRNA
Transient downregulation of PHP was performed with
chemically synthesized siRNA (Qiagen; Hilden, Germany).
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Several siRNA sequences were tested for their potency to
downregulate PHP in SN56 cells. The siRNA correspond-
ing to the nucleotides 5’-aac tga gaa gat caa agc caa-3’ of
the murine PHP sequence yielded best results. As negative
control SN56 cells were transfected with scrambled
siRNA. Transfection of SN56 cells with siRNA was per-
formed as described in transfection of SN56 cells.
Analysis of cell damage
For nuclear staining with Hoechst 33258 cells were seeded
on 24-well-plates and cultured under appropriate condi-
tions. The cells were washed with 37°C PBS, fixed for
30 min with 4% paraformaldehyd and then incubated with
Hoechst 33258 (10 μg/ml) for 30 min at RT. Nuclear mor-
phology was analyzed with the fluorescence microscope
Axiovert 25 from Zeiss (Oberkochen, Germany).
Acetylcholine measurement
Sample preparation for ACh measurement was performed
as described previously [17]. In brief, SN56 cells were
washed with PBS and were detached with trypsin-EDTA
solution. Then trypsin was inhibited by 10% FBS in buffer
wash solution (BWS). BWS contained 90 mM NaCl,
30 mM KCl, 20 mM 4-(2-hydroxyethyl)-1-piperazineetha-
nesulfonic acid (HEPES), 0.02 mM EDTA, 32 mM sucrose,
0.015 mM neostigmine and 10% FBS, pH 7.4. For further
preparation cells were washed twice with BWS (FBS free).
Subsequently, cells for ACh measurement were resus-
pended in 80% acetonitrile containing 0.015 mM neostig-
mine and the cells for protein quantification taken from
the same tube were resuspended in 10 mM HEPES (pH
7.4), 2 mM EDTA, 0.1 mM PMSF and 1 mM BZ. Acetyl-
choline content was measured by fast liquid chromatogra-
phy-tandem mass spectrometry (LC-MS/MS) as described
previously [17].
Statistical analysis
All values are given as mean +/- standard deviation. Signif-
icant differences between the means were calculated by
analysis of variance (ANOVA) followed by Scheffé-test.
Results
Overexpression of PHP and cell damage
Overexpression of PHP in SN56 cells was performed by
using pIRES2-AcGFP1-PHP as a vector. A time-depen-
dent analysis of PHP overexpression showed that best
results were achieved 48 h after transfection with the
PHP-overexpression vector (data not shown). As shown
in Figure 1A PHP is overexpressed in SN56 cells by using
pIRES2-AcGFP1-PHP vector. In contrast, when using a
GFP-overexpression vector PHP was indeed not overex-
pressed. To exclude unspecific effects of protein overex-
pression, the inactive histidine 53 mutant of PHP was
overexpressed, too.
The influence of overexpression of PHP on cell viabi-
lity was analysed by Hoechst 33258 staining. PHP over-
expression for 48 h significantly caused damage of SN56
cells of about 12% in comparison to the negative control
of GFP overexpression (Figure 1B). Inactive H53A-PHP
overexpression did also cause cell damage of about 5%,
but in a significantly reduced manner compared to
wt-PHP overexpression.
PHP overexpression and acetylcholine level
Previous studies showed that PHP dephosphorylates ACL
and therefore diminishes ACL activity [13,14]. ACL is
essential for providing acetyl-CoA for ACh synthesis
[16]. We measured the ACh content of SN56 cells 48 h
after transfection with the PHP overexpression vector. It
is shown in Figure 2 that PHP overexpression decreases
significantly the ACh content of SN56 cells from about
700 to about 500 pmol/mg protein. To exclude negative
effects of raised PHP protein content itself, the inactive
H53A-PHP mutant was overexpressed, too. But the over-
expression of the inactive PHP mutant did not cause a
decrease of ACh content of SN56 cells compared to con-
trol (GFP-overexpression).
PHP downregulation and cell viability
Our data suggest that PHP overexpression induces cell
damage. As shown before the decreased cell viability cor-
relates with a decreased phosphorylation state of ACL
[14]. Furthermore, the ACh content of SN56 cells was sig-
nificantly reduced after PHP overexpression (Figure 2).
To test the causal role of PHP in these processes, we
downregulated PHP with RNAi-technique and analysed
the influence of PHP downregulation on the viability and
the ACh content of SN56 cells. Previous experiments
showed that PHP is almost completely downregulated
after 48 h of treatment with siRNA against PHP. Western
Blot analysis showed that PHP is significantly downregu-
lated 48 h after treatment with siRNA against PHP in
comparison to the negative control (Figure 3A). Viability
of SN56 cells was tested by staining with Hoechst 33258
at 48 h after transfection with siRNA against PHP. In line
with PHP downregulation in other neuronal cells [13] cell
viability was not affected after PHP downregulation
(Figure 3B). In contrast to PHP overexpression which
damaged SN56 cells, PHP downregulation did not affect
cell viability at all.
Acetylcholine level after PHP downregulation
In this work we wanted to find out whether PHP down-
regulation could modify the ACh content of SN56 cells.
Therefore, we downregulated PHP for 48 h with the
RNAi-technique and measured the ACh content of these
SN56 cells by LC-MS/MS according to [17]. A signifi-
cantly increased ACh content of SN56 cells was detected
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after PHP downregulation in contrast to the negative
control where scrambled siRNA was used and PHP was
not downregulated (Figure 4). The ACh content of SN56
cells increased from about 150 to 350 pmol ACh/mg pro-
tein after PHP downregulation. Obviously, there is a cor-
relation between PHP downregulation and an increased
ACh level in SN56 cells.
Discussion
One of the most important substrates of PHP known so
far is ACL [10]. PHP regulates the phosphorylation state
and thereby the activity of ACL. ACL activity is decreased
by PHP-catalyzed ACL dephosphorylation and increased
by ACL phosphorylation. Downregulation of PHP
expression causes less dephosphorylation of ACL and
probably maintains a higher activity of this enzyme.
ACL is a cytosolic enzyme which cleaves citrate trans-
ported out from the mitochondria into acetyl-CoA and
oxaloacetate [22]. Acetyl-CoA is used in cytosol for fatty
acid and ACh synthesis whereas oxaloacetate is taken up
by the mitochondria again and may stimulate energy
metabolism. Beside the acetylcholine precursor synthesis
via ACL, biosynthesis of the neurotransmitter ACh is
dependent on both the regulated, rate-limiting choline
uptake step and choline acetyltransferase-catalyzed linking
of choline and acetyl-coA [22]
In previous experiments we could show that an
increased expression of PHP leads to damage of neurons
Figure 1 Overexpression of PHP in cholinergic neurons causes cell damage. (A) Western blot analysis shows overexpression of PHP and of
its inactive mutant in SN56 cells after 48 h. An amount of 100 ng recombinant PHP and 50 μg total cell lysate were applied for SDS-PAGE. PHP
was detected by the monoclonal PHP antibody. As a loading control a-tubulin was used and detected by the monoclonal a-tubulin antibody.
(B) Percentage of damaged SN56 cells was determined by Hoechst 33258 staining and was increased after PHP overexpression. However, cell
damage was less pronounced after overexpression of the H53A-PHP mutant. Values are given as means ± standard deviationof 6 experiments.
***p < 0.001 and **p < 0.01 compared to GFP-overexpression; ##p < 0.01 compared to H53A-overexpression (ANOVA followed by Scheffé-test)
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and endothelial cells [13,14,18]. Our hypothesis was that
higher content of PHP in the cells means a higher depho-
sphorylation rate of PHP substrates like ACL. On the
other hand, a lowered ACL activity leads to a reduced
acetyl-CoA production and, consequently, to a reduced
ACh content as demonstrated in the present paper. In
addition, the reduced fatty acid and energy metabolism
after PHP overexpression [13] could essentially contri-
bute to the decreased viability of SN56 cells found in our
study.
Taken together, overexpression of PHP is disadvanta-
geous for neurons whereas downregulation of PHP
synthesis increases the ACh content of cholinergic cells
and, at least, does not negatively influence cell viability.
PHP-H53A was overexpressed in SN56 cells and the
increase of this inactive protein does influence the viabi-
lity of SN56 cells slightly, but in a significantly reduced
manner compared to wt-PHP overexpression. The ACh
content of the cholinergic cells was not affected by this
inactive PHP mutant.
Inhibition or downregulation of PHP seems to be a
highly interesting strategy for treatment of AD. The
brains of AD patients show indeed decreased ACh [23]
and glucose contents [24]. To increase the ACh amount
of AD brains by ACh esterase inhibitors is the most
effective therapy of AD at the moment [25]. Decrease of
PHP activity could cause not only an increase of ACL
activity and consequently ACh content but also an
increase of energy metabolism in neuronal cells. In
other words, PHP inhibition might improve the
damaged transmission of cholinergic neurons and, addi-
tionally, support their viability.
In conclusion, PHP could be an appropriate target for
AD therapy because downregulation of PHP activity
leads to an increase of ACL content as well as fatty
acids and energy metabolism. Thus, functional activity
and viability of cholinergic neurons might be improved
by targeting PHP.
Figure 2 Acetylcholine content after PHP overexpression. To
measure the ACh content of SN56 cells, the cells were harvested 48
h after transfection with the overexpression vectors and ACh was
measured by LC-MS/MS. Values are given as means ± standard
deviation of 4 experiments. **p < 0.01 compared to H53A-
overexpression; n.s. (not significant) compared to GFP-
overexpression (ANOVA followed by Scheffé-test). Additionally, p <
0.01 between GFP- and PHP-overexpression was determined
Figure 3 Downregulation of PHP in cholinergic neurons and its
impact on cell damage. Control: SN56 cells transfected without
siRNA. Negative (Neg.) control: SN56 cells transfected with scrambled
siRNA. PHP-siRNA: transfected with siRNA against PHP. (A) PHP
downregulation could be detected by Western blot analysis 48 h
after transfection. An amount of 100 ng rec. PHP and 50 μg total
cell lysate were applied for SDS-PAGE followed by Western blot
analysis. PHP was detected by the monoclonal PHP antibody. As a
loading control a-tubulin was used and detected by the
monoclonal a-tubulin antibody. (B) Hoechst 33258 staining shows
that PHP downregulation did not significantly induce cell damage
after 48 h. Values are given as means ± standard deviation of 8
experiments. n.s. compared to neg. control (ANOVA followed by
Scheffé-test)
Figure 4 Acetylcholine content and PHP downregulation. SN56
cells were transfected with siRNA. After 48 h of siRNA treatment
cells were harvested for ACh measurement. Values are given as
means ± standard deviation of 4 experiments. ***p < 0.001
compared to neg. control (ANOVA followed by Scheffé-test)
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